Atlas Trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Leukemia, Myelogenous, Chronic, BCR-ABL Positive

RecordFirmDate
Impact of a Pharmaceutical Care Model in the Management of Chronic Myeloid Leukemia Patients (NCT03090477)UCSI University2017-03-24
Study to Evaluate Tolerability, Safety, Pharmacokinetics and Preliminary Efficacy of PF-114 for Oral Administration in Adults With Ph+ Chronic Myeloid Leukemia, Which is Resistant to the 2-nd Generation Bcr-Abl Inhibitors or Has T315I Mutation in the BCR-ABL Gene (NCT02885766)Fusion Pharma LLC2016-07-01
Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia (NCT02687425)Meng Li2016-02-01
Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (NCT01768689)pia raanani2013-10-01
Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study (NCT02389972)Bristol-Myers Squibb2013-04-11
Multicenter Single-arm Pilot Study Evaluating Efficacy of Nilotinib in CML Patients With Molecular Relapse After Glivec Discontinuation Within the Context of the STIM Trials (STIM and STIM2) (NCT01774630)University Hospital, Bordeaux2013-04-10
Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia (NCT01437202)Asan Medical Center2011-09-01
Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients (NCT01511289)Il-Yang Pharm. Co., Ltd.2011-08-01
Dasatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia in Japan (NCT01464411)Kanto CML Study Group2011-07-01
A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML (NCT02896842)Versailles Hospital2010-09-01
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI (NCT01602952)Il-Yang Pharm. Co., Ltd.2008-07-01
Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) (NCT02480608)University of Leipzig2004-04-01
An Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-Alpha (NCT00171223)Novartis Pharmaceuticals1999-12-06

Track Leukemia, Myelogenous, Chronic, BCR-ABL Positive automatically

Every clearance here is in the API, with alerts when new ones post.